Clinical Trials Browser

Withdrawn × Busulfan × CNS × Clear all

NCT00836628 2020-08-05

Study of Busulfan for Refractory Central Nervous System (CNS) Tumors

Phase 1 Withdrawn

Brain Neoplasms

NCT00874315 2015-10-16

Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL.

Phase 2 Withdrawn

Neuroblastoma, Recurrence